Search Login Register
Tretinoin
(Retinoic Acid)
Summary
Description:
An important regulator of GENE EXPRESSION during growth and development, and in NEOPLASMS. Tretinoin, also known as retinoic acid and derived from maternal VITAMIN A, is essential for normal GROWTH; and EMBRYONIC DEVELOPMENT. An excess of tretinoin can be teratogenic. It is used in the treatment of PSORIASIS; ACNE VULGARIS; and several other SKIN DISEASES. It has also been approved for use in promyelocytic leukemia (LEUKEMIA, PROMYELOCYTIC, ACUTE).
Also Known As:
Retinoic Acid; all-trans-Retinoic Acid; Retin-A; Vitamin A Acid; Vesanoid Show All >>
Networked: 8030
relevant articles (594 outcomes,
952 trials/studies)
for this Drug
Key Diseases for which Tretinoin is
Relevant
-
Acute Promyelocytic Leukemia
:
255 outcomes 112 studies in 1287 results
-
Acne Vulgaris
:
47 outcomes 76 studies in 343 results
-
Neoplasms (Cancer)
:
43 outcomes 105 studies in 976 results
-
Leukemia
:
39 outcomes 52 studies in 583 results
-
Melanosis (Freckles)
:
19 outcomes 12 studies in 60 results
Show All >>
Drugs Related to Tretinoin
-
arsenic trioxide (Trisenox)
-
Tretinoin (Retinoic Acid)
-
hydroquinone (Black and White)
-
retinoic acid receptor alpha
-
Retinoids
-
Vitamin A (Retinol)
-
clindamycin-2-phosphate (Clindets)
-
Benzoyl Peroxide
-
Aligeron (AS 2)
-
promyelocytic leukemia-retinoic acid receptor alpha fusion oncoprotein
Show All >>
Therapies Related to Tretinoin
-
Drug Therapy (Chemotherapy)
-
Microspheres (Microsphere)
-
Aftercare (After-Treatment)
-
Remission Induction
-
Chemoprevention
Show All >>
CureHunter Inc. provides medical information and specifically does NOT provide medical advice.
© Copyright 2003-2016 CureHunter Inc., MeSH copyright NLM, Journal Articles copyright original owners.